HSD17B13 Inhibitors are Hepatoprotective and Anti-inflammatory in a Mouse Model of Autoimmune Hepatitis

Discovery and Characterization of Hydroxysteroid 17-β Dehydrogenase 13 Inhibitors

Characterization of Mouse and Human HSD17B13 Structure and Activity

An Improved Toolkit for In Vitro hMPV Characterization

EDP-297: A Novel, Highly Potent, Farnesoid X Receptor Agonist: Results of a Phase 1 Study in Healthy Subjects

Pharmacological Inhibition of HSD17B13 Is Hepatoprotective In Mouse Models of Liver Injury

Phase 1 Study of EDP-305, a Novel Once-Daily Oral Farnesoid X Receptor Agonist, in Healthy Subjects and Those with Presumptive Nonalcoholic Fatty Liver Disease

EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study

Mechanism and structural basis of small molecule inhibition of PAPD5 and PAPD7

Discovery and Characterization of EDP-721, a Novel Hepatitis B Virus RNA Destabilizer